ZÜRICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use…
Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at the Tencent WE…
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership…
Program Celebrates 20 Years as One of the Largest in US and a Destination for Patients Seeking Expertise, Experience and…
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,…
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's…
SAN FRANCISCO, Nov. 13, 2024 /PRNewswire/ -- Celesta Capital, a global deep tech venture capital firm, today announced it is…
Four Recipients' Work From Israel, Sweden, Canada and South Africa Earns The Sigourney Award-2024 SEATTLE, Nov. 12, 2024 /PRNewswire/ --…
Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective TreatmentMINNEAPOLIS and CARMARTHENSHIRE, United Kingdom,…